HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)

Chloe L. Thio, Eric C. Seaberg, Richard Skolasky, John Phair, Barbara Visscher, Alvaro Muñoz, David L. Thomas

Research output: Contribution to journalArticlepeer-review

828 Scopus citations

Abstract

Background: Although coinfection with HIV-1 and hepatitis B virus (HBV) is common, few long-term studies on liver-disease mortality in coinfected people have been undertaken. Our aim was to examine liver-related mortality among people at risk for HIV-1 and HBV infections. Methods: We used data from a multicentre, prospective cohort study to classify 5293 men who had sex with men, according to their HIV-1 antibody status, ascertained semiannually, and their hepatitis-B surface antigen status (HBsAg), which we ascertained at baseline. Mortality rates were estimated in terms of person-years and Poisson regression methods were used to test for signifiance of relative risks. Findings: 326 (6%) men were HBsAg positive, of whom 213 (65%) were HIV-1 positive. Of the 4967 HBsAg negative men, 2346 (47%) were infected with HIV-1. The liver-related mortality rate was 1·1/1000 person years, and was higher in men with HIV-1 and HBsAg (14·2/1000) than in those with only HIV-1 infection (1·7/1000, p<0·001) or only HBsAg (0·8/1000, p<0·001). In coinfected individuals, the liver-related mortality rate was highest with lower nadir CD4+ cell counts and was twice as high after 1996, when highly active antiretroviral therapy (HAART) was introduced. Interpretation: Individuals coinfected with HIV-1 and HBV, especially those with low CD4+ nadir counts, are at increased risk for liver-related mortality, underscoring the importance of prevention, identification, and comprehensive management of hepatitis B in people infected with HIV-1.

Original languageEnglish (US)
Pages (from-to)1921-1926
Number of pages6
JournalLancet
Volume360
Issue number9349
DOIs
StatePublished - Dec 14 2002

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)'. Together they form a unique fingerprint.

Cite this